The TLR1/2 agonist PAM3CSK4 instructs commitment of human hematopoietic stem cells to a myeloid cell fate
De Luca, K, Frances-Duvert, V, Asensio, M-J, Ihsani, R, Debien, E, Taillardet, M, Verhoeyen, E, Bella, C, Lantheaume, S, Genestier, L, Defrance, T
Published in Leukemia (01.11.2009)
Published in Leukemia (01.11.2009)
Get full text
Journal Article
The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate
De Luca, K, Frances-Duvert, V, Asensio, M-J, Ihsani, R, Debien, E, Taillardet, M, Verhoeyen, E, Bella, C, Lantheaume, S, Genestier, L, Defrance, T
Published in Leukemia (01.11.2009)
Published in Leukemia (01.11.2009)
Get full text
Journal Article
The TLR1/2 agonist [PAM.sub.3][CSK.sub.4] instructs commitment of human hematopoietic stem cells to a myeloid cell fate
De Luca, K, Frances-Duvert, V, Asensio, M.-J, Ihsani, R, Debien, E, Taillardet, M, Verhoeyen, E, Bella, C, Lantheaumeo, S, Genestier, L, Defrance, T
Published in Leukemia (01.11.2009)
Published in Leukemia (01.11.2009)
Get full text
Journal Article
The TLR1/2 agonist PAM sub(3)CSK sub(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate
De Luca, K, Frances-Duvert, V, Asensio, M-J, Ihsani, R, Debien, E, Taillardet, M, Verhoeyen, E, Bella, C, Lantheaume, S, Genestier, L, Defrance, T
Published in Leukemia (01.11.2009)
Published in Leukemia (01.11.2009)
Get full text
Journal Article